ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements
Neogen Chemicals' subsidiary, Neogen Morita New Materials Limited, approved a preferential issue of 7,20,000 equity shares worth ₹76.80 Crore to Morita Investment Limited.
CRISIL Ratings reaffirmed and revised outlooks for Neogen Chemicals and subsidiary Neogen Ionics' facilities and debt, citing improved financial risk profile and completed QIP funding.
Neogen Chemicals has paid the interest on its listed non-convertible debentures for September 2026, totaling ₹1.63 Crore.
Neogen Chemicals Ltd has submitted its quarterly shareholding pattern disclosure as per SEBI regulations. This routine filing details the current equity distribution among promoters and public shareholders.
Neogen Chemicals Limited allotted equity shares via a Qualified Institutional Placement (QIP). The allotment increases the total paid-up share capital of the company.
Neogen Chemicals is raising funds via a Qualified Institutional Placement of 26.61 lakh equity shares. This issuance is valued at approximately ₹600 Crore.
Neogen Chemicals successfully concluded its QIP, issuing 26,60,753 equity shares at an issue price of ₹2,255 per share, raising funds from qualified institutional buyers.
Neogen Chemicals Limited has opened its Qualified Institutional Placement (QIP) with a floor price of ₹2,189.73 per share, as approved by its Fund-Raising Committee.
Neogen Chemicals received a GST show-cause demand notice for ₹6.97 Crore for FY 2022-23. The company is evaluating the notice and intends to file a response.
Neogen Chemicals Ltd has fixed September 15, 2026, as the record date for the interest payment on its NCDs (ISIN: INE136S07013), payable on September 30, 2026.
Neogen reported robust Q1 FY27 results with 34% revenue growth and 53% EBITDA growth. Strategy pivots toward battery materials and organo-lithium, supported by a ₹600 crore QIP for de-leveraging.
Neogen reported robust Q1 FY27 results with consolidated revenue growing 34% and PAT up 67% YoY. Growth was driven by the Organolithium portfolio and the ramp-up of Neogen Ionics.
Neogen Chemicals Ltd reported revenue from operations of ₹250.3 Cr (+34.1% YoY) and net profit of ₹17.1 Cr (+66.0% YoY) for Q1 FY27.
Neogen reported Q4 FY26 revenue of ₹247 crore (+22% YoY) and EBITDA of ₹44 crore (+21% YoY). The company is transitioning towards a battery materials-led portfolio with massive capex in Pakhajan and Dahej.
Neogen delivered volume-led Q4 growth but faces significant execution hurdles as battery project costs ballooned by ₹250cr+ while timelines shifted to the right.
Neogen Chemicals delivered strong Q4 FY26 results with consolidated revenue growing 22% YoY to ₹247cr. Strategy focuses on high-growth battery materials and agrochem segments.
Neogen Chemicals Ltd reported revenue from operations of ₹246.6 Cr (+21.6% YoY) and net profit of ₹11.4 Cr (+375.0% YoY) for Q4 FY26.